Christopher HallamSeries on Legislative Reform of Drug Policies No. 26
The World Health Organisation (WHO) estimates that some 5.5 billion people around the globe inhabit countries with low to non-existent access to controlled medicines and have inadequate access to treatment for moderate to severe pain. This figure translates to over 80 per cent of the world's population. Only in a small number of wealthy countries do citizens stand a reasonable chance of gaining adequate access to pain care, though even here room for improvement remains. According to the International Narcotics Control Board, recent data indicate that more than 90 per cent of the consumption of strong opioids takes place in Australia, New Zealand, Canada, the United States and Western Europe.
Marcus DayBriefing Series on Drug Markets and Violence, Nr 3
Caribbean states face challenges of youth involvement in crime, violence, gangs and other anti-social activities. It is not uncommonly heard the “drug problem” is to be blamed for this. This briefing wants to show this relation is far more complex and often misunderstood.
Download the full report (PDF)Read more...
Wells Bennett and John WalshBrookings Center for Effective Public Management
Two U.S. states have legalized recreational marijuana, and more may follow; the Obama administration has conditionally accepted these experiments. Such actions are in obvious tension with three international treaties that together commit the United States to punish and even criminalize activity related to recreational marijuana. The administration asserts that its policy complies with the treaties because they leave room for flexibility and prosecutorial discretion.
Download the briefing (PDF - outside link)Read more...
Global Commission on Drug Policy (GCDP)
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.
Download full report (PDF)Read more...
Christopher Hallam Dave Bewley-Taylor Martin JelsmaSeries on Legislative Reform of Drug Policies Nr. 25
While often viewed as an obscure technical issue, the problem of scheduling lies at the core of the functioning of the international drug control system. Scheduling – the classification of a substance within a graded system of controls and restrictions, or 'schedules' – must take place in order for a substance to be included in the international control framework, and determines the type and intensity of controls to be applied. For this reason, the topic is of central importance.
Download the briefing (PDF)Read more...
The History of Cannabis in the UN Drug Control System and Options For ReformDave Bewley-Taylor Tom Blickman Martin JelsmaTransnational Institute / Global Drug Policy Observatory
The cannabis plant has been used for spiritual, medicinal and recreational purposes since the early days of civilization. In this report the Transnational Institute and the Global Drug Policy Observatory describe in detail the history of international control and how cannabis was included in the current UN drug control system. Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value.Read more...
Press release by TNI/GDPO
Tuesday, March 4, 2014
As the UN International Narcotics Control Board (INCB) launches its annual report on Tuesday, 4 March, amidst an unprecedented crisis in the international drug control regime, leading drug policy reform experts have called on the INCB and related UN institutions to urgently open up a constructive dialogue on international drug policy reform.Read more...
New developments in Harm ReductionGrazia ZuffaSeries on Legislative Reform of Drug Policies Nr. 24
By taking cues from users’ self-regulation strategies, it is possible to design innovative operational models for drug services as well as drug policies, strengthening Harm Reduction as an alternative approach to the disease model. A significant body of research on cocaine users recruited outside captive populations – that is, studies based on samples of users who have not been enrolled through drug addiction services – has been carried out in many European countries and outside Europe. These studies show a variety of patterns and trajectories of use other than “addictive” use.
Download the briefing (PDF)Read more...
Drug control should respect human rights
The Transnational Institute (TNI) has always believed in the need to find global answers to global problems, been a strong defender of multilateralism and an advocate of a well-functioning United Nations which stands as the guarantor of universal human rights. On the drugs question, our position is straightforward: drug control should respect human rights.Read more...
Recent developments in cannabis regulation
Cannabis is the most widely produced and consumed illicit substance globally. A significant number of states have long engaged in soft defection from the UN drug control regime in relation to tolerant policies on the personal possession, cultivation and use of cannabis. Recently, there has been growing debate within political circles on the benefits of regulated cannabis markets. This has been driven by a number of factors, including the continuing illegality of supply, the associated and often violent involvement of criminal elements and the use of finite criminal justice resources. In this section you will find an overview of our most recent blogs on the issue.
Latest: Mexico legislators consider regulating marijuana to protect human right, Zara Snapp, July 14, 2014